pathology-congress-2017-scientifictracks-abstracts

5 / 18

Page 20
conferenceseries.com
Volume 7, Issue 5 (Suppl) J Clin Exp Pathol
ISSN: 2161-0681 JCEP, an open access journal Pathology Congress 2017
November 13-14, 2017
NOVEMBER 13-14, 2017 OSAKA, JAPAN
14th Asia Pacific Pathology Congress
Update on prostatic adenocarcinoma
Turki Omar Al-Hussain
King Faisal Specialist Hospital and Research Center, KSA
Prostatic adenocarcinma is the second most common malignancy worldwide. There have been new updates on pathology
of prostatic adenocarcinoma. Recently, the International Society of Urological Pathology held a consensus conference in
2014 which was published in 2015. This conference predominantly deliberated with definition of various grading patterns
of usual prostatic adenocarcinoma, grading of intraductal carcinoma and the new grade groups. Most of these updates were
implemented and applied in the new 2016 WHO Classification of Tumors of the Prostate. The presentation will discuss the new
update of prostatic adenocarcinoma with focus on grading system.
Biography
Turki Omar Al-Hussain has completed his MBBS degree in King Saud University, Riyadh, KSA. He has completed Pathology training at King Faisal Specialist
Hospital in 2008 and then he joined the University of North Carolina at Chapel Hill, USA as Renal Pathology Fellow (2009-2010). In 2011, he has completed another
year of Fellowship in Genitourinary Pathology at John Hopkins Hospital, Baltimore, USA. Currently, he is a Consultant Pathologist specializing in Nephropathology
and Urologic Pathology. He is also the Director of Pathology Residency Training Program and has published 27 papers in peer reviewed journals, and has been
invited as speaker in several conferences locally and internationally.
Turki Omar Al-Hussain, J Clin Exp Pathol 2017, 7:5 (Suppl)
DOI: 10.4172/2161-0681-C1-040